Search Results 1251-1260 of 24404 for Phase

1. Phase 2 Study of JK07 in Chronic Heart Failure - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. A Study of Neuroimaging to Assess the Underlying Disease Progression in Progressive Apraxia of Speech - Mayo Clinic

   Study phase. 0. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. Radiation Therapy, Paclitaxel, and Carboplatin with or without Trastuzumab in Treating Patients with Esophageal Cancer - Mayo Clinic

   This randomized phase III trial studies how well radiation therapy, paclitaxel, and carboplatin with or without trastuzumab work in treating patients with ...

4. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial (FASTEST) - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

5. Safety And Efficacy Study Of The Medtronic CoreValve® System In The Treatment Of Severe, Symptomatic Aortic Stenosis In Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). - Mayo Clinic

   This is a non-randomized phase of the pivotal clinical trial. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease ...

6. Zephyrus II: Effectiveness and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

7. Phase 1b Open-Label Study of PEGPH20 With Pembrolizumab - Mayo Clinic

   This is a phase 1b study evaluating a combination of PEGPH20 and pembrolizumab in hyaluronan-high (HA-high) subjects with relapsed/refractory Non-Small Cell ...

8. Tucatinib and Trastuzumab for Patients with HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

   This is a phase II trial that will study how well tucatinib (ONT-380) and trastuzumab work in treating patients with colorectal cancer with a specific genetic ...

9. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

10. GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...